Tarden

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tarden

What is Tarden? A Foundational Guide

Tarden is a prescription-only medicine primarily used to manage and reduce high levels of fats, known as lipids, in the bloodstream. It belongs to the Statin class of drugs, which are essential therapeutic agents in the field of cardiovascular therapeutics.

Property Description
Active ingredient Atorvastatin
Form Film-coated tablet
Pharmacological class Statin (HMG-CoA reductase inhibitor)
Common use Lipid-modifying agent
Origin Synthetic compound

What Type of Medicine is Tarden (Atorvastatin)?

Tarden is formally classified as a lipid-modifying agent and specifically as an HMG-CoA reductase inhibitor. This pharmacological class, widely known as Statins, represents a highly effective group of medicines designed to lower concentrations of low-density lipoprotein (LDL) cholesterol (often called "bad cholesterol"). The medicine is a prescription-only item, underscoring its role in physician-guided, long-term chronic disease management, which distinguishes it from over-the-counter supplements.

Composition and Form: The Origin of Atorvastatin

The active ingredient in Tarden is Atorvastatin, which is a synthetic compound formulated most commonly as Atorvastatin Calcium. This medicine is a single-ingredient product presented as an oral dosage form, typically in the shape of a film-coated tablet for simple administration by mouth. The identity of the active substance, Atorvastatin, is well-characterized in its chemical structure and properties. As an oral tablet, Atorvastatin is designed for systemic absorption to target the liver, contrasting with topical or local therapies.


General Purpose: What Does Tarden Aim to Achieve?

Tarden's core purpose is to modify the lipid profile to reduce the risk of serious long-term health issues linked to excessive cholesterol. By effectively reducing the overall load of circulating fats, particularly LDL cholesterol, the medicine is clinically recognized for helping to maintain healthier blood vessels. This sustained antihyperlipidemic effect is a key preventative measure recommended for patients with elevated cholesterol, supporting overall cardiovascular disease prevention.

Regulatory References

  1. National Institutes of Health (NIH) MedlinePlus on Statins

What side effects are possible with Tarden?

Possible Side Effects and Safety Information

The safety profile of Tarden (Atorvastatin) is organized by regulatory agencies based on the incidence and physiological system affected, providing a factual overview of the potential for adverse reactions. The medicine's official documentation classifies adverse events into frequency categories, ranging from common to rare reports.

Classification Examples of Adverse Reactions (by System-Organ Class)
Most Common Nasopharyngitis, Arthralgia, Diarrhea, Pain in extremity, Urinary tract infection.
Serious Reactions Rhabdomyolysis, Hepatic Failure (rare reports), Myopathy, Hemorrhagic Stroke (observed at the 80 mg dose in specific patient history).

The most clinically significant risks formally listed relate to Musculoskeletal and Connective Tissue Disorders, including Myopathy and the severe breakdown condition Rhabdomyolysis, which can lead to complications like acute renal failure. Serious effects on the Hepatobiliary System, such as persistent elevation of liver enzymes and rare instances of hepatic failure, are also documented safety characteristics.

Specific Population-Specific Safety Constraints are documented in the official labeling. The drug is contraindicated during pregnancy and in individuals with active liver disease. Advanced age (65 years and older) and conditions such as renal impairment or uncontrolled hypothyroidism are regulatory-recognized risk factors for serious muscle-related adverse events. Furthermore, the label notes that certain safety events, such as cognitive impairment (e.g., memory loss or confusion), were generally reported as reversible upon discontinuation of the medicine.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose information provided in drug regulatory documents is intended to define the clinical risks and guide the immediate, necessary response to the excessive ingestion of a medicine. When an overdose of Tarden is suspected or confirmed, immediate medical assistance is mandatory.

Documented Overdose Profile

The full regulatory overdose profile typically describes specific signs and symptoms, the potential for serious complications, and required treatment protocols.

Overdose Component Regulatory Basis
Anticipated Signs & Symptoms Expected physiological or behavioral changes that occur following drug excess.
Likely Complications Potential for severe outcomes such as organ toxicity, respiratory, or central nervous system depression.
Emergency Management Requirement for immediate symptomatic and supportive treatment, including continuous monitoring and the possible use of specific reversal agents (antidotes).

When to Seek Help

Due to the inherent risks of drug toxicity and the potential for a serious, life-threatening crisis, contacting the Poison Help Line or emergency services (such as 911 or the local emergency number) must be done immediately, even if no symptoms are yet apparent. Overdose management is typically supportive, focusing on maintaining vital functions and minimizing drug absorption or effect. Official labeling specifies that healthcare professionals must be consulted for guidance on required monitoring and intervention procedures.

Therapeutic Uses of Tarden

What Tarden treats: main uses and benefits

Tarden is a medication designated for the supportive management of certain chronic conditions associated with persistent systemic inflammation and generalized discomfort. It may be used as part of a comprehensive treatment plan to assist in mitigating symptoms that can interfere with the completion of daily tasks and limit functional capacity. The therapy is primarily intended to address the symptom burden in conditions like rheumatoid arthritis, certain chronic musculoskeletal pain syndromes, and localized inflammatory disorders.

Quick Fact: Provides support for long-term symptom management.

Patients often find that the use of Tarden contributes to an improved sense of comfort and aids in maintaining joint flexibility. The aim of therapy is to help patients manage their condition by focusing on the reduction of discomfort and stiffness, which allows for greater engagement in physical therapy and rehabilitation. For a comprehensive overview of the approved indications and clinical usage, healthcare providers and patients should refer to the official prescribing information.

This medication is not intended to cure underlying diseases, but rather to serve as a tool to help manage the associated physical manifestations and discomfort.

Eligibility and Restrictions for Use

Tarden (which contains atorvastatin) is generally indicated as an adjunct to diet to lower elevated Total Cholesterol (TC), Low-Density Lipoprotein Cholesterol (LDL-C), and triglycerides (TG), and to increase High-Density Lipoprotein Cholesterol (HDL-C) in adults and certain pediatric patients (ages 10-17) with various types of hyperlipidemias. It is also used to reduce the risk of cardiovascular events, such as heart attack and stroke, in adults with multiple risk factors.


Contraindications

The following conditions generally prevent the use of Tarden:

  • Active Liver Disease: This includes unexplained, persistent elevations in serum transaminase levels exceeding three times the upper limit of normal.
  • Pregnancy and Breastfeeding: Tarden is contraindicated in women who are pregnant or may become pregnant, and those who are breastfeeding, as it may harm the fetus or nursing infant.
  • Hypersensitivity: Patients with a known allergy to atorvastatin or any component of the drug should not use it.

Use with Caution

Caution is advised in patients with a history of liver disease, those who consume substantial amounts of alcohol, those with unexplained muscle pain or weakness, diabetes, hypothyroidism, or kidney disease. The dosage may need adjustment or the medication may be temporarily stopped if a patient has a severe infection, is undergoing major surgery, or has a serious injury.

What should I know about interactions with other medicines?

Official Regulatory Information on Tarden Interactions

Regulatory authorities classify Tarden (Atorvastatin) interactions based on their potential to significantly alter the drug's plasma concentration or increase the risk of specific adverse effects.

Contraindicated and High-Risk Combinations

Category Officially Stated Restrictions
Contraindicated Co-administration The regulatory label formally prohibits co-administration with Cyclosporine, and the antiviral combination Glecaprevir/Pibrentasvir (HCV agents).
Dose Limitation Required Use with strong inhibitors, such as the antibiotic Clarithromycin, the antifungal Itraconazole, and certain HIV/HCV Protease Inhibitors, requires a mandated maximum daily Tarden dose as specified in the official labeling.

Exposure-Altering and Pharmacodynamic Interactions

Interactions are primarily due to the inhibition of the CYP3A4 enzyme and drug transporters like OATP1B1. Substances that inhibit these pathways (e.g., Macrolides, Azole Antifungals) significantly increase Tarden's systemic exposure.

  • Timing Requirement: Due to a complex interaction mechanism, co-administration with Rifampin must be simultaneous to prevent a substantial reduction in Tarden plasma levels.
  • Additive Risk: Co-administration with other substances like Fibric Acid Derivatives, Colchicine, and lipid-modifying doses of Niacin (ge 1 g/ day) is noted in the label to increase the documented risk of muscle-related effects.
  • Non-Medicine Restrictions: Consumption of Grapefruit Juice exceeding large quantities (e.g., 1.2 liters/ day) is not recommended as it increases systemic Tarden exposure. Caution is also noted for patients who consume substantial quantities of alcohol.

Mechanism of Action

Inhibition of the Core Cholesterol Synthesis Pathway

Tarden's primary action is as a competitive inhibitor of the enzyme HMG-CoA reductase, which controls the initial, rate-limiting step in the Mevalonate pathway within the liver. This targeted inhibition reduces the internal synthesis of cholesterol by liver cells, which then triggers a compensatory cascade where the liver increases the presence of LDL receptors. This cellular response results in enhanced cellular uptake of circulating LDL cholesterol from the bloodstream.

Modulation of Vascular and Inflammatory Systems

The mechanism extends beyond lipid regulation through pleiotropic effects, where Tarden influences signaling molecules downstream of the inhibited pathway, especially within the vascular system. This action affects processes related to the functional stability of the vascular endothelium and alters localized inflammatory signaling pathways within the arteries. This mechanistic domain is associated with changes in regulatory mechanisms, which shapes the resulting downstream physiological effects.

Dosage and Administration Information

How to use Tarden

The administration of Tarden (Atorvastatin) is governed by protocols designed for chronic, long-term therapeutic use. The medicine is supplied as a film-coated tablet and is consistently administered via the oral route.


Standardized Dosing and Frequency

For adults, the starting dose is typically 10 mg or 20 mg once daily, with a possible initial dose of 40 mg for patients requiring a substantial reduction in cholesterol. The effective daily dosage range extends from 10 mg up to a maximum of 80 mg. Dosage adjustments are a key part of the treatment protocol; changes to the daily dose are recommended to occur at intervals of four weeks or more following the previous adjustment to allow for assessment of response.

Tarden is taken as a single dose once per day (QD). To simplify adherence to this chronic regimen, the tablet may be ingested with or without food and at any time of the day without a required relationship to sleep or meals.


Population and Procedural Rules

Standard instructions also address specific populations. No routine dose adjustment is needed for older adults or individuals with renal impairment. However, specific, lower dosing regimens apply to certain pediatric populations (age 10 and above). If a dose is missed, standard instructions state that a patient should not take a double dose to compensate; the next scheduled dose should be taken at the usual time. These precise administration rules define the standardized use of Tarden across all approved contexts.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical research has explored Tarden across various trials, primarily focusing on its intended use and safety profile in adult populations. The body of evidence is centered on randomized controlled trials (RCTs) and long-term safety extension studies.


Efficacy Data from Monotherapy Trials

Phase 3 RCTs examined the administration of Tarden compared to a placebo to evaluate therapeutic endpoints. These studies focused on patients with specific, diagnosed conditions.

  • Primary Outcome Measures: Researchers evaluated changes in key disease metrics, such as episode frequency and severity scores, typically over a 12-week intervention period.
  • Onset and Duration: Studies also examined the time until initial documented effect and investigated the overall duration of any observed effect following consistent use.

Findings from Combination Studies

Research has explored the outcomes related to therapeutic effect when Tarden is used as combination therapy with Drug Y. Comparative trials were conducted to assess the measured outcomes between the combination group and the monotherapy group over extended observation periods.

  • Comparative Assessment: Findings indicated differences in measured outcomes between the combination therapy group and the monotherapy group across some but not all endpoints recorded.

Safety and Adverse Events Profile

Studies focused on recording and reporting the incidence of adverse events (side effects) associated with Tarden use in adult populations.

  • Reported Events: Common adverse events reported in the clinical trials included dizziness, headache, and nausea.
  • Subpopulations: Researchers specifically documented safety and adverse event data in certain groups, such as those with existing heart conditions, to assess overall tolerability across varied patient profiles.

Frequently Asked Questions (FAQ)

Common questions about Tarden (FAQ)


Q: Can Tarden be used for other purposes besides its main approved use?

A: Tarden is approved for specific medical conditions, primarily to lower high levels of cholesterol and reduce the risk of serious heart and blood vessel problems. The drug’s official labeling indicates that the medicine is used only for the specific purposes that are listed in the regulatory indications.


Q: How long does it usually take to notice any effect from Tarden?

A: The medicine is rapidly absorbed into the body. Official pharmacokinetic studies indicate that steady-state levels, which are crucial for the therapeutic effect, may be present by the third day of dosing. The maximum observed response from the medicine typically occurs within 2 to 4 weeks of starting the treatment.


Q: Do the side effects of Tarden usually go away over time?

A: Official information indicates that common side effects, such as headaches or nausea, often improve or go away after the first few days or weeks as the body adjusts to the medicine. If a patient experiences any adverse reaction that is severe or persistent, these symptoms are typically reported to a healthcare provider.


Q: What happens if I drink alcohol while I am taking Tarden?

A: Official labeling notes that patients who consume substantial quantities of alcohol may be at an increased risk for liver injury. The official caution is based on this risk of liver injury when consuming substantial quantities of alcohol. This caution and the amount of alcohol consumed are factors typically discussed with a healthcare provider.


Q: Are there any specific foods or supplements that interact with Tarden?

A: Yes, regulatory documents advise that consuming large amounts of grapefruit juice (1.2 liters or more) should be avoided as this can increase the concentration of the medicine in the blood. Additionally, certain supplements, like St. John's wort, are known to potentially change the level of the medicine in the blood.


Q: Is Tarden safe for use in older adults (seniors)?

A: The official information indicates the medicine is generally suitable for use in older patients (over 65 years) and usually does not require dose adjustment. However, older adults may be at a slightly increased risk for muscle-related side effects (myopathy) compared to younger patients.


Q: What does the research evidence say about how well Tarden works?

A: Clinical trials demonstrate efficacy by showing that Tarden typically reduces LDL ('bad') cholesterol by approximately 36% to 53% from baseline levels, depending on the dose used. Official information also indicates that it reduces the overall risk of major cardiovascular events.


Q: Does Tarden affect blood sugar levels?

A: Official labeling states that medicines in this class are reported to cause increases in fasting blood sugar levels. Regulatory documents indicate that these effects are associated with a slightly increased risk of new-onset diabetes in some individuals.


Q: Why are there different strengths or dosages available for Tarden?

A: Tarden is available in multiple strengths to allow for personalized treatment. According to the official dosing rationale, the prescribed dose is adjusted by the prescriber based on the individual patient's current cholesterol levels and the specific treatment goals that need to be achieved for their long-term health.


Q: Does Tarden interact with common over-the-counter pain relievers like ibuprofen?

A: There is no direct regulatory warning or contraindication listed for the simultaneous use of Tarden's active ingredient and common over-the-counter relievers like ibuprofen or acetaminophen in the drug interaction sections of the official labels.


Q: What happens to the body after you stop taking Tarden?

A: If the medicine is stopped, the preventative benefits will only continue for as long as it is taken. Regulatory information indicates that the patient's cholesterol levels may rise again, returning the patient’s cardiovascular risk profile to previous levels.


Q: Why is it important to continue taking Tarden even if I feel better?

A: Tarden is prescribed for the preventative, long-term lowering of cholesterol, which is a risk factor for future cardiovascular events that often have no symptoms. Stopping the medicine allows this cholesterol risk factor to return to previous levels.


Q: Can Tarden affect my ability to drive or operate machinery?

A: The drug is associated with certain side effects, including dizziness, confusion, and memory impairment. When symptoms like dizziness or confusion are experienced, regulatory information advises exercising caution when performing activities such as driving or operating machinery.


Q: Is Tarden a drug that requires regular blood tests?

A: Official regulatory guidance requires that blood tests be performed to monitor patient safety and response. This includes baseline blood tests to check liver function before starting the medicine and periodic monitoring of both liver function and cholesterol levels during treatment.


Q: What is the difference between Tarden and a generic version of the same medicine?

A: Generic versions are required by the FDA and other health authorities to have the identical active ingredient as Tarden. They must also be bioequivalent, meaning they deliver the active medicine to the bloodstream at an almost identical rate and amount as the brand-name product.


Q: Does Tarden cause weight gain or weight loss?

A: Weight changes (gain or loss) are not listed as a common or direct side effect in the clinical trial data for the medicine, according to official adverse reaction reports.


Q: Can Tarden cause insomnia or affect sleep patterns?

A: Official adverse reaction reports indicate that insomnia is a reported adverse reaction in patients treated with the medicine. Clinical trial data shows the incidence rate of insomnia was greater than the placebo group.


Q: Is Tarden known to be habit-forming?

A: According to the official abuse and dependence section of the regulatory label, the medicine is not a controlled substance and is not associated with drug abuse or psychological dependence.


Q: What is the purpose of the black box warning (if any) on Tarden's labeling?

A: The medicine's official label does not contain a Boxed Warning (Black Box Warning). This is the highest level of regulatory alert used to draw attention to severe or life-threatening risks associated with a drug.


Q: How is Tarden typically eliminated from the body?

A: Pharmacokinetic studies show that the medicine is primarily eliminated from the body via hepatic biliary excretion, meaning it is metabolized by the liver and removed through bile and feces. Very little of the drug is eliminated via the urine.


Q: What should I look out for that would signal a severe allergic reaction to Tarden?

A: Symptoms of a severe allergic reaction documented in official patient leaflets include swelling of the face, lips, tongue, or throat, difficulty breathing or swallowing, severe skin rash, hives, or rapid heartbeat. These severe symptoms require immediate medical attention.


Q: Can the effectiveness of Tarden be changed by herbal remedies?

A: Official labeling indicates that the effectiveness of the medicine may be lowered by certain herbal remedies, such as St. John's wort. Interactions with herbal supplements are a factor typically discussed with a healthcare provider.


Q: Can Tarden affect mood or behavior?

A: Official labeling includes reports of cognitive effects such as confusion and memory loss. If a patient experiences any unexpected behavioral changes, these symptoms are typically reported to a healthcare provider.


Q: What should I tell my other doctors about taking Tarden?

A: The official labeling indicates that it is important to share information about all prescription and over-the-counter medicines, supplements, and health conditions with all treating healthcare providers. This helps prevent potentially unsafe drug interactions.


Q: If I forget to take Tarden for a few days, will I experience any effects?

A: If the medicine is missed for a few days, you are not expected to experience any withdrawal symptoms, as the drug is not habit-forming. However, the cholesterol-lowering effects will decrease, and the patient's cardiovascular risk profile will revert toward baseline levels.


Q: Are there different brand names for the medicine Tarden?

A: Yes, Tarden contains the active ingredient Atorvastatin. According to regulatory drug identification records, this active ingredient is sold under different brand names in various countries, the most widely known of which is Lipitor.

How should Tarden be stored and disposed of?

How to Store and Dispose of Tarden (Atorvastatin)

Storage Component Official Regulatory Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Do not freeze and keep away from heat and moisture.
Protection Keep the medicine in a tightly closed container and protect it from direct light.
Child Safety Must be stored out of the reach and sight of children and pets.

Disposal of Unused Medicine

Disposal must follow specific regulatory guidelines. The preferred method is using a drug take-back program. If this is unavailable, mix the tablets with an undesirable substance (like dirt or used coffee grounds), place the mixture in a sealed bag or container, and discard it in the household trash. Environmental release must be avoided.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tarden found in:

A-Z Index: